Your session is about to expire
← Back to Search
Behavioral Intervention
Health Education for Prostate Cancer
N/A
Recruiting
Led By Mitchell R. Humphreys, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12-month post treatment decision
Awards & highlights
Study Summary
This trial is designing a tool to provide tailored info about prostate cancer to men, to improve understanding and satisfaction with treatment decisions.
Who is the study for?
This trial is for English-speaking men with prostate cancer and their healthcare advocates, if they have one. It's not open to those who are mentally unable to participate or have no treatment options because of other health issues.Check my eligibility
What is being tested?
The study is testing an adaptive virtual consultation tool (AVCT) designed to provide personalized education on prostate cancer based on the patient's literacy, learning preferences, and specific disease characteristics.See study design
What are the potential side effects?
Since this trial involves educational tools rather than medical treatments, there are no direct physical side effects. However, participants may experience varying levels of satisfaction with the information provided.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12-month post treatment decision
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12-month post treatment decision
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Health outcomes for cancer recurrence using PSA
Health outcomes for sexual function
Health outcomes for sexual function using SHIM score
+3 moreTrial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Arm 1 (AVCT)Experimental Treatment2 Interventions
Patients participate in an adaptive virtual consultation on trial.
Group II: Arm 2 (non-AVCT)Active Control2 Interventions
Patients participate in a non-adaptive virtual consultation on trial.
Group III: Arm 3 (information-only)Active Control2 Interventions
Patients receive information-only on trial.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Health Education
2014
Completed Phase 3
~4010
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,215 Previous Clinical Trials
3,766,943 Total Patients Enrolled
33 Trials studying Prostate Cancer
8,088 Patients Enrolled for Prostate Cancer
Mitchell R. Humphreys, M.D.Principal InvestigatorMayo Clinic
2 Previous Clinical Trials
128 Total Patients Enrolled
Mitchell R HumphreysPrincipal InvestigatorMayo Clinic
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there still an opportunity to enroll in the trial?
"Affirmative. According to clinicaltrials.gov, this medical trial has been open since February 10th 2022 and was updated on August 28th 2023. 300 participants need to be recruited for the research across 1 centre location."
Answered by AI
How many test subjects are currently being observed in this clinical experiment?
"Affirmative. According to information published on clinicaltrials.gov, this trial is actively looking for participants and was initially posted on February 10th 2022 before being modified most recently on August 28th 2023. The research requires 300 people from one medical centre to be enrolled."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger